Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection

Objective To elucidate the association between antiviral therapy and extrahepatic outcomes in individuals infected with HCV. Methods This nationwide cohort study screened 293 480 Taiwanese residents with HCV infection and excluded those with substantial comorbidity. A total of 12 384 eligible patients who had received pegylated interferon plus ribavirin between 1 October 2003 and 31 December 2010 were enrolled in the treated cohort; they were matched 1 : 2 with 24 768 untreated controls in the propensity score and post-diagnosis treatment-free period. The incidences of end-stage renal disease (ESRD), acute coronary syndrome (ACS), ischaemic stroke and catastrophic autoimmune diseases were calculated after adjustment for competing mortality. Results The treated and untreated cohorts were followed up for a mean (±SD) duration of 3.3 (±2.5) and 3.2 (±2.4) years, respectively, until 31 December 2011. The calculated 8-year cumulative incidences of ESRD, ACS, ischaemic stroke and autoimmune catastrophes between treated and untreated patients were 0.15% vs 1.32% (p
Source: Gut - Category: Gastroenterology Authors: Tags: Hepatology Source Type: research

Related Links:

BACKGROUND: Heat stroke is an emergent condition characterized by hyperthermia (>40  °C/>104 °F) and nervous system dysregulation. There are two primary etiologies: exertional which occurs during physical activity and non-exertional which occurs durin...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Environmental Issues, Climate, Geophysics Source Type: news
ConclusionWe herein reported a subphrenic abscess due to Clostridium perfringens after hepatic resection for hepatocellular carcinoma following emphysematous cholecystitis.
Source: International Journal of Surgery Case Reports - Category: Surgery Source Type: research
This study demonstrates that successful DAA therapy for HCV provides an initial rapid resolution of liver inflammation followed by a steady improvement in liver fibrosis and metabolic liver function.Journal of Viral Hepatitis
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Publication date: Available online 26 January 2020Source: Comparative Immunology, Microbiology and Infectious DiseasesAuthor(s): Hamed Esmaeil Lashgarian, Maryam Karkhane, Abdolrazagh Marzban, Mohammad Yazdi, Kiana ShahzamaniAbstractGastrointestinal (GI) disorders including a wide range of infectious, inflammatory, autoimmune, etc. disorders. Inflammatory bowel and celiac disease are non-fatal but overwhelming GI associated disorders. IBD and celiac’s complications, besides the great suffering, disturb the normal life of the patients and make them involved in mental and physical problems. The emerging role of genetic...
Source: Comparative Immunology, Microbiology and Infectious Diseases - Category: Infectious Diseases Source Type: research
Undergoing earlier menopause is a sign of a greater burden of age-related damage and dysfunction, so it should not be surprising to see that this correlates with a greater incidence of chronic disease in the years thereafter. People with a greater burden of cell and tissue damage tend to exhibit all of the manifestations of aging earlier than their less damaged peers. These variations in damage burden and consequences from individual to individual are near all the results of lifestyle choices, particularly smoking, weight, and exercise, and environmental factors such as exposure to chronic viral infection. Genetics plays o...
Source: Fight Aging! - Category: Research Authors: Tags: Daily News Source Type: blogs
HIGH blood pressure does not have noticeable symptoms. However, if left untreated, serious health problems could ensue including heart attacks or strokes. Eating this brightly coloured vegetable could help to lower a person's reading. What is it?
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
      ·Application is being reviewed under FDA ’s Real-Time Oncology Review pilot programmeBasel, 27 January 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the completion of a supplemental Biologics License Application (sBLA) submission to the US Food and Drug Administration (FDA) for Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab), for the treatment of people with unresectab le hepatocellular carcinoma (HCC) who have not received prior systemic therapy. The FDA is reviewing the application under the Real-Time Oncology Review pilot programme, wh...
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news
The life science technology company drives significant consumer interaction and education around stroke awareness utilizing SMS engagement.(PRWeb January 27, 2020)Read the full story at https://www.prweb.com/releases/pulse_healths_pulse_engagement_cloud_platform_leverages_sms_to_increase_stroke_awareness/prweb16856728.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news
.
Source: Infectious Diseases - Category: Infectious Diseases Authors: Source Type: research
ConclusionsAmong NSCLC patients in an equal access health system, the likelihood of late stage at diagnosis differed by specific comorbid diseases.
Source: Cancer Causes and Control - Category: Cancer & Oncology Source Type: research
More News: Antiviral Therapy | Autoimmune Disease | Gastroenterology | Hepatitis | Hepatitis C | Ischemic Stroke | Stroke | Study